The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•13 June 2026•

1 min read

Institutional Investors Boost Stakes in Merck and Disney

Key Facts

1First National Bank of Omaha increased its stake in Merck & Co. by 261.7% during the fourth quarter.

2First National Bank of Omaha nearly doubled its holdings in The Walt Disney Company to 219,462 shares valued at $25.1 million.

3Summit Financial LLC increased its position in Merck & Co. by 14.6%, bringing its total holding value to $14.6 million.

Amid a broader trend of portfolio rebalancing by major funds, institutional activity has intensified within the healthcare and entertainment sectors. First National Bank of Omaha increased its stake in Merck & Co. by 261.7% during the fourth quarter and nearly doubled its holdings in The Walt Disney Company to 219,462 shares, valued at $25.1 million. Additionally, Summit Financial LLC raised its position in Merck by 14.6%, bringing its total holding value to $14.6 million.

This institutional accumulation follows positive quarterly results, with Merck benefiting from its acquisition of TARGAN and Disney demonstrating solid revenue growth. Compared to peers, while Pfizer (PFE) faces different valuation dynamics and Netflix (NFLX) focuses on margin expansion, the shift of capital toward Disney and Merck suggests a preference for their specific growth catalysts and cash flow stability per market data.

Traders should monitor price action relative to recent levels, with MRK closing at $119.05 and DIS at $100.04 (close June 12, 2026). While the upcoming economic calendar shows medium-impact events like Fed speeches, no immediate corporate catalysts are scheduled, leaving the focus on technical support levels established near $118.83 for MRK and $99.54 for DIS.